| 164 | 0 | 60 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 阐述不同脂肪含量的饲料对定植了高甘油三酯人群肠道菌群大鼠脂代谢和肠道菌群构成情况的影响。方法 10周龄无菌SD大鼠,按体重随机分为3组,每组6只,对照组定植甘油三酯正常人群肠道菌群喂饲无菌鼠基础饲料,另两组定植高甘油三酯人群肠道菌群分别喂饲无菌鼠基础饲料和高脂饲料。以每100克体重1 mL的剂量给大鼠灌胃粪便菌液,隔天进行,共3次,之后进行2周菌群适应性生长,再用基础饲料或高脂饲料分别饲养相应组大鼠9周。检测大鼠体重变化、血脂水平、肝脏脂质沉积情况、肝功能与肠道菌群构成。结果 肠道菌群定植并持续不同饲料喂养9周后,基础饲料组大鼠的体重和脏器指数与对照组的差异无统计学意义,而高脂饲料组体重和脏器指数均显著高于基础饲料组(P<0.05或P<0.01)。基础饲料组血脂水平和肝功与对照组相比差异均无统计学意义,而高脂饲料组血清总胆固醇和低密度脂蛋白胆固醇水平分别为基础饲料组的1.4倍和1.8倍(P<0.01),丙氨酸氨基转移酶水平也显著高于基础饲料组(P<0.05)。基础饲料组肝脏脂滴面积比(18%)与对照组(17%)的差异无统计学意义,高脂饲料组肝脏脂滴面积比(41%)高于基础饲料组(P<0.01)。基础饲料组的肠道菌群α-多样性指数与对照组相近,而高脂饲料组Shannon指数低于基础饲料组(P<0.05)。在门水平和属水平上,高脂饲料组与基础饲料组肠道菌群构成差异明显,高脂饲料组厚壁菌门与拟杆菌门的相对丰度比值(3.37)高于基础饲料组(0.46)。血清脂质水平与肠道内特定菌群呈现显著关联关系。结论 膳食干预有助于改善血脂异常者的脂代谢水平,并有益于维持其正常的肠道菌群构成。
Abstract:OBJECTIVE To elucidate the effects of diets differing in fat content on lipid metabolism and gut microbiota composition in rats colonized with the intestinal microbiota of hypertriglyceridemic humans.METHODS Ten-week-old germ-free SD rats were randomly assigned by body weight into three groups of six animals each. The control group was inoculated with gut microbiota from normotriglyceridemic humans and maintained on a standard sterile basal diet, whereas the other two groups received microbiota from hypertriglyceridemic humans and were fed either the same basal diet(NDG group)or a high-fat diet(HFDG group), respectively. A fecal microbial suspension was administered by gavage at 1 mL per 100 g body weight on alternate days for a total of three inoculations, followed by a 2-week period to allow microbiota engraftment and adaptation. Subsequently, the rats were maintained on their respective basal or high-fat diets for 9 weeks. Body-weight changes, serum lipid profiles, hepatic lipid accumulation, liver function indices, and gut microbiota composition were assessed.RESULTS After intestinal microbiota colonization followed by 9 weeks of continuous feeding on their respective diets, the NDG group exhibited higher body weight, liver index, epididymal fat index, and subcutaneous fat index than the control group, although none of these differences reached statistical significance. In contrast, the HFDG group was significantly elevated for all these parameters versus the control group, while its brown adipose tissue index was markedly lower. Serum lipid and hepatic function analyses revealed no significant differences between the control and NDG groups. Relative to the control group, the HFDG group displayed a 1.47-fold increase in serum total cholesterol(TC) and a 2.06-fold increase in LDL-C, both statistically significant. Serum ALT in the HFDG group was significantly higher than in controls(P<0.05), whereas AST showed an upward trend but lacked statistical significance. Histologically, the HFDG livers contained markedly more red-stained lipid droplets, and the droplet area fraction was significantly greater than in controls. Concurrently, microbial diversity in the HFDG group was lower than in the control group, and both phylum-and genus-level community structures diverged substantially from those of the NDG group. Furthermore, specific intestinal taxa were significantly correlated with circulating lipid levels, whereas no significant differences were observed between the control and NDG groups.CONCLUSION Dietary intervention can improve lipid metabolism and maintain normal gut microbiota composition in individuals with dyslipidemia.
[1] 兰咏梅,慈彩虹,安颜,等.裕固族血脂异常人群肠道菌群结构特征分析[J].中国微生态学杂志,2023,35(6):621-629.
[2] JAMIESON P E,CARBONERO F,STEVENS J F.Dietary (poly)phenols mitigate inflammatory bowel disease:therapeutic targets,mechanisms of action,and clinical observations[J].Curr Res Food Sci,2023,6:100521.
[3] WANG L,ZENG B,LIU Z,et al.Green tea polyphenols modulate colonic microbiota diversity and lipid metabolism in high-fat diet treated HFA mice[J].J Food Sci,2018,83(3):864-873.
[4] TANG X,ZHANG K ,HE R.The association of triglyceride-glucose and triglyceride-glucose related indices with the risk of heart disease in a national[J].Cardiovasc Diabetol,2025,24:54.
[5] GHAZANFAR H,JAVED N,QASIM A,et al.Metabolic dysfunction-associated steatohepatitis and progression to hepatocellular carcinoma:a literature review[J].Cancers,2024 ,16(6):1214.
[6] 孔鸿晖.基于多组学技术筛选血脂异常患者的肠道菌群及其血清标志物[D].湛江:广东医科大学,2024.
[7] HSU C L,SCHNABL B.The gut-liver axis and gut microbiota in health and liver disease[J].Nat Rev Microbiol,2023,21(11):719-733.
[8] 崔馨月,石璠,郑丽红,等.丁酸盐在炎症性肠病中的免疫调节机制研究进展[J].河北医药,2024,46(9):1397-1402.
[9] 李婕,丁虎.脂蛋白a在心血管疾病中的研究新进展[J].中国全科医学,2024,27(36):4505-4514.
[10] ZHANG Y,ZHANG L,LI Z,et al.Gualou-Xiebai-Banxia-Tang regulates liver-gut axis to ameliorate metabolic syndrome in HFD-fed mice[J].Phytomedicine,2024,132:155320.
[11] 黄立颖,张欢,李裕明,等.胃肠内分泌细胞分化和功能研究进展[J].中华内分泌代谢杂志,2024,40(6):538-544.
基本信息:
DOI:10.19813/j.cnki.weishengyanjiu.2025.05.007
中图分类号:R589.2
引用信息:
[1]许逸凡,张兵,张曦月,等.不同脂肪含量饲料对定植高甘油三酯人群肠道菌群大鼠脂代谢和肠道菌群的影响[J].卫生研究,2025,54(05):751-756.DOI:10.19813/j.cnki.weishengyanjiu.2025.05.007.
基金信息:
国家重点研发计划(No.2021YFE0114200)
2025-09-17
2025-09-17